Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

10x Genomics (TXG) Receivables - Other (2024 - 2025)

10x Genomics (TXG) has disclosed Receivables - Other for 2 consecutive years, with $35.5 million as the latest value for Q4 2025.

  • Quarterly Receivables - Other rose 5754.79% to $35.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $35.5 million through Dec 2025, up 5754.79% year-over-year, with the annual reading at $35.5 million for FY2025, 5754.79% up from the prior year.
  • Receivables - Other hit $35.5 million in Q4 2025 for 10x Genomics, down from $52.8 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $69.1 million in Q2 2025 to a low of $606000.0 in Q4 2024.